Answer
For finerenone (Kerendia), a decision must be made to discontinue breastfeeding or discontinue/avoid treatment, weighing breastfeeding benefits for the child against treatment benefits for the woman, because a risk to newborns or infants cannot be excluded.
Sources for this answer
- Kerendia 10 mg film coated tabletsBayer plc · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked